Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: JAMA Oncol. 2015 Apr 9;1(3):359–368. doi: 10.1001/jamaoncol.2015.0493

Fig. 1.

Fig. 1

Kaplan-Meier melanoma-specific survival probabilities by primary melanoma NRAS and BRAF mutational status are shown for participants with melanomas (n=892). Patients with single primary melanoma were diagnosed in 2000. Patient follow-up for vital status was complete to the end of 2007. A. Melanoma-specific survival for all primary melanomas; B. Melanoma-specific survival for higher risk (T2b or higher AJCC stage) primary melanomas); C. Melanoma-specific survival for lower risk (T2a or lower AJCC stage) primary melanomas.